178 related articles for article (PubMed ID: 20144401)
1. Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.
Geho WB; Geho HC; Lau JR; Gana TJ
J Diabetes Sci Technol; 2009 Nov; 3(6):1451-9. PubMed ID: 20144401
[TBL] [Abstract][Full Text] [Related]
2. The effects of HDV-insulin on carbohydrate metabolism in Type 1 diabetic patients.
Davis SN; Geho B; Tate D; Galassetti P; Lau J; Granner D; Mann S
J Diabetes Complications; 2001; 15(5):227-33. PubMed ID: 11522495
[TBL] [Abstract][Full Text] [Related]
3. Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity.
El Leithy ES; Abdel-Bar HM; Ali RA
Int J Pharm; 2019 Nov; 571():118708. PubMed ID: 31593805
[TBL] [Abstract][Full Text] [Related]
4. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
[TBL] [Abstract][Full Text] [Related]
5. Oral insulin delivery: existing barriers and current counter-strategies.
Gedawy A; Martinez J; Al-Salami H; Dass CR
J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
[TBL] [Abstract][Full Text] [Related]
6. Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation.
Dal S; Jeandidier N; Schaschkow A; Spizzo AH; Seyfritz E; Sookhareea C; Bietiger W; Péronet C; Moreau F; Pinget M; Maillard E; Sigrist S
Fundam Clin Pharmacol; 2015 Oct; 29(5):488-98. PubMed ID: 26095147
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
8. Influence of glucosamine on the bioactivity of insulin delivered subcutaneously and in an oral nanodelivery system.
Al-Kurdi ZI; Chowdhry BZ; Leharne SA; Qinna NA; Al Omari MM; Badwan AA
Drug Des Devel Ther; 2015; 9():6167-76. PubMed ID: 26640369
[TBL] [Abstract][Full Text] [Related]
9. "Oil-soluble" reversed lipid nanoparticles for oral insulin delivery.
Wang T; Shen L; Zhang Y; Li H; Wang Y; Quan D
J Nanobiotechnology; 2020 Jul; 18(1):98. PubMed ID: 32680576
[TBL] [Abstract][Full Text] [Related]
10. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles.
Woitiski CB; Neufeld RJ; Soares AF; Figueiredo IV; Veiga FJ; Carvalho RA
Drug Dev Ind Pharm; 2012 Dec; 38(12):1441-50. PubMed ID: 22324290
[TBL] [Abstract][Full Text] [Related]
15. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
16. Comparing the enhancement efficiency between liposomes and microbubbles for insulin pulmonary absorption.
Xu YY; Lu CT; Fu HX; Zhao YZ; Yang W; Li X; Zhang L; Li XK; Zhang M
Diabetes Technol Ther; 2011 Jul; 13(7):759-65. PubMed ID: 21510752
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
19. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
20. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
Wong CY; Al-Salami H; Dass CR
Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
